<I>Diabetes Technology & Therapeutics (DTT)</i> (IMAGE) Mary Ann Liebert, Inc./Genetic Engineering News Caption <a target="_blank" href="http://www.liebertpub.com/dia"><i>Diabetes Technology & Therapeutics</i> (DTT)</a> is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Led by Editor-in-Chief Satish Garg, MD, the Journal covers topics that include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications. Tables of contents and a free sample issue may be viewed on the <i>Diabetes Technology & Therapeutics</i> (DTT) website. DTT is the official journal of the Advanced Technologies & Treatments for Diabetes (ATTD) Conference. Credit ©Mary Ann Liebert, Inc., publishers Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.